Pfizer India Site Slammed By FDA

Warning Letter Criticizes Sterility Testing And Environmental Monitoring

 
• By Joanne S. Eglovitch

Pfizer's third US FDA warning letter since 2018 goes to injectables site in Vizag, India; tells the company to up its game in sterility testing and in the microbiology lab.

Warning Rubber Stamp
FDA Warning Letter Faults Pfizer's Sterility Testing, Lab Controls • Source: Shutterstock

More from Manufacturing

More from Business